KR102909306B1 - Foam toothpaste composition with excellent plaque removal effect - Google Patents

Foam toothpaste composition with excellent plaque removal effect

Info

Publication number
KR102909306B1
KR102909306B1 KR1020230070990A KR20230070990A KR102909306B1 KR 102909306 B1 KR102909306 B1 KR 102909306B1 KR 1020230070990 A KR1020230070990 A KR 1020230070990A KR 20230070990 A KR20230070990 A KR 20230070990A KR 102909306 B1 KR102909306 B1 KR 102909306B1
Authority
KR
South Korea
Prior art keywords
weight
parts
extract
sodium
toothpaste composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020230070990A
Other languages
Korean (ko)
Other versions
KR20240173255A (en
Inventor
최현성
Original Assignee
주식회사 바오메디텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 바오메디텍 filed Critical 주식회사 바오메디텍
Priority to KR1020230070990A priority Critical patent/KR102909306B1/en
Priority to PCT/KR2023/007817 priority patent/WO2024248202A1/en
Publication of KR20240173255A publication Critical patent/KR20240173255A/en
Application granted granted Critical
Publication of KR102909306B1 publication Critical patent/KR102909306B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • A61K8/21Fluorides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/591Mixtures of compounds not provided for by any of the codes A61K2800/592 - A61K2800/596

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 녹차 추출물, 오미자 추출물, 상추 추출물, 콜라비 추출물, 카렌듈라 추출물, 삼칠 추출물, 작약 추출물, 짚신나물 추출물, 흑미강 추출물 및 땅콩 추출물을 포함하는 거품 치약 조성물에 관한 것이다. 천연물로부터 얻은 원료가 포함된 상기 거품 치약 조성물은 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas gingivalis) 등의 구강 내 세균에 항균 효능 및 구취 제거 효능이 있으며, 구강 내 잇몸에 프라그 제거 효능이 우수하여 치석이 쌓이는 것을 방지하는 기능이 뛰어나다. 이에 상기 거품 치약 조성물을 사용함으로써 보다 위생적이고 청결한 구강 관리를 할 수 있게 한다. The present invention relates to a foaming toothpaste composition comprising a green tea extract, a Schisandra chinensis extract, a lettuce extract, a kohlrabi extract, a calendula extract, a Samchil extract, a peony extract, a Agrimonia japonica extract, a black rice bran extract, and a peanut extract. The foaming toothpaste composition comprising raw materials obtained from natural products has an antibacterial effect against oral bacteria such as Streptococcus mutans and Porphyromonas gingivalis and an effect of eliminating bad breath, and has an excellent effect of removing plaque from the gums in the oral cavity, thereby having an excellent function of preventing tartar build-up. Therefore, by using the foaming toothpaste composition, more hygienic and clean oral care can be achieved.

Description

프라그 제거 효능이 우수한 거품치약 조성물 {Foam toothpaste composition with excellent plaque removal effect}Foam toothpaste composition with excellent plaque removal effect

본 발명은 녹차 추출물, 오미자 추출물, 상추 추출물, 콜라비 추출물, 카렌듈라 추출물, 삼칠 추출물, 작약 추출물, 짚신나물 추출물, 흑미강 추출물 및 땅콩 추출물을 포함하여, 치태 및 백태와 같은 프라그 제거 효능, 치석 예방, 구취 제거, 항균 효능을 갖는 거품 치약 조성물에 관한 것이다. The present invention relates to a foaming toothpaste composition having plaque removal effects such as dental plaque and white plaque prevention, bad breath removal, and antibacterial effects, comprising a green tea extract, an omija extract, a lettuce extract, a kohlrabi extract, a calendula extract, a ginseng extract, a peony extract, a straw flower extract, a black rice bran extract, and a peanut extract.

사람의 구강 안에는 400종류 이상의 세균이 번식하고 있으며, 그 균수는 100억개에 달하고 있다. 또한, 이에 더하여 타액에는 108~109CFU/㎖ 수준의 균수가 검출되고 있다. 치아는 미세한 구멍이 다수 개 천공되어 있어서 충치를 일으키는 세균이 상기한 구멍으로 들어가 치아를 병들게 하는데 이것이 충치이다. 이러한 충치는 치아에서 가장 흔히 볼 수 있는 대표적인 질환의 하나로 치아우식증이라고도 한다. 구강 내 음식물이 내산성 연쇄상 구균과 유산균에 의해 부패되고 산에 의해 치아의 성분이 파괴되는 감염성 세균성 질환이다. 우리나라에서는 영구 치아의 충치 이환율이 약 80%에 이르고, 한 사람이 평균 2~3개의 충치를 가지고 있는 것으로 보고되고 있다.More than 400 types of bacteria thrive in the human oral cavity, totaling 10 billion. Furthermore, saliva has been found to contain bacteria at levels of 108 to 109 CFU/㎖. Teeth have numerous microscopic pores, allowing cavity-causing bacteria to enter these pores and damage the teeth, which is known as cavities. Cavities are one of the most common dental diseases, also known as dental caries. It is an infectious bacterial disease caused by the decay of food in the mouth by acid-resistant streptococci and lactic acid bacteria, and the destruction of tooth components by acid. In Korea, the prevalence of caries in permanent teeth is reported to be approximately 80%, with an average person having 2 to 3 cavities.

충치를 일으키는 원인은 여러 가지가 복합적으로 작용하고 있는 것으로 밝혀져 있지만 가장 중요한 것은 치태이다. 치태에는 여러 세균이 섞여 있는데, 특히 내산성 연쇄상 구균과 유산균이 많고 그 중에서 스트렙토코쿠스 뮤탄스(Streptococcus mutans)가 주요 충치균으로 알려져 있다. 이같은 스트렙토코쿠스 뮤탄스는 치아의 표면에 부착하여 성장하면서 음식물 내의 당을 이용하여 산을 생성하여 치아를 부식시키고 동시에 치아 골세포에 침입하여 각종 치조 골 부식과 잇몸병을 발생시킨다. 좀더 자세하게는 충치의 발생은 충치 원인균에 의해서 치태가 치면에 형성하는 과정을 제1단계로 하고, 치태내에서 유기산이 생성되는 과정을 제2단계로, 치태내에서 생성된 유기산, 단백질 분해효소 등에 의해서 치아 표면을 구성하는 무기질을 탈회하고 나아가 유기질을 용해하여 가는 제3단계로 이루어진다. 또한 치주질환의 경우, 치면 및 치주 조직에 부착된 치태가 치주질환의 발생과 진행의 주된 원인이 되는 바, 치태내의 세균에 의해서 유해한 대사 산물이나 세균성 효소를 생성하여 그 결과로서 치은염을 유발시켜 발생하고 진전되는 것으로 알려져 있다. Although it has been revealed that various factors work together to cause tooth decay, the most important one is dental plaque. Dental plaque contains a variety of bacteria, particularly acid-resistant streptococci and lactic acid bacteria, of which Streptococcus mutans is known as the main cariogenic bacteria. Streptococcus mutans attaches to the tooth surface and grows, producing acid using sugars in food, which corrodes the tooth and simultaneously invades dental osteocytes, causing various types of alveolar bone decay and gum disease. More specifically, the development of tooth decay begins with the first stage of dental plaque formation on the tooth surface by cariogenic bacteria. The second stage is the production of organic acids within the plaque. The third stage is the demineralization of the inorganic substances constituting the tooth surface by organic acids and proteolytic enzymes produced within the plaque, and further dissolves the organic substances. In addition, in the case of periodontal disease, dental plaque attached to the tooth surface and periodontal tissue is the main cause of the occurrence and progression of periodontal disease, and it is known that the disease occurs and progresses by producing harmful metabolic products or bacterial enzymes by bacteria in dental plaque, which in turn induces gingivitis.

구취는 구강 및 인접기관으로부터 유래되는 냄새를 말하며 많은 사람들이 구취로 일상 생활에 불편을 호소하고 있다. 구취의 85~90%가 구강에서 유래하며, 특히, 혀의 뒷쪽에서 유래하고 있다. 구취의 주요 성분은 휘발성 황화합물인데, 휘발성 황화합물의 전체량 중 90%가 시스테인으로부터 만들어지는 황화수소(hydrogen sulfide)와 메치오닌으로부터 만들어지는 메틸머캡탄(methyl mercaptan) 및 디메틸설파이드(dimethyl sulfide)이다. 이러한 성분들은 주로 혐기성 세균이 분비하는 단백질 효소에 의해서 생성되며, 혀의 뒷쪽이 가장 중요한 서식지가 된다. 이 부위는 타액에 의해 세정작용이 잘 되지 않고, 많은 작은 함몰이 있어 세균이 지속적으로 살아가는 장소가 된다. 혐기성 세균에 의한 휘발성 황화합물 생성이 구취의 원인으로 가장 중요하지만, 그 외 충치와 치주염 등과 같은 구강질환에 의해서도 발생한다. 구취를 발생시키는데 많은 종류의 혐기성 세균이 관여하지만, 특히, 구취 발생의 대표적인 세균은 많은 종류와 많은 양의 효소를 분비하는 포르피로모나스 진지발리스(Porphyromonas gingivalis), 프레보텔라 인터메디아(Prevotella intermedia), 푸소박테리움 누클레아툼(Fusobacterium nucleatum), 박테오이데스 포르시두스(Bacteoides forsythus), 트레포네마 데티코라(Treponema deticola) 등으로서, 치주염을 일으키는 대표적인 원인균으로도 알려져 있다. 구취를 억제하기 위해서는 구취의 주성분인 휘발성 황화합물을 생성하는 혐기성 세균의 증식을 억제하는 것이 가장 효과적이기 때문에, 종래에는 혀로부터 세균의 증식기질을 제거하기 위해 혀 세정기(tongue scraper)를 사용하여 설태를 제거하거나, 혐기성 세균의 증식이나 혐기성 세균에 의한 휘발성 황화합물 생성을 억제하기 위하여 염화아연(zinc chloride)과 같은 금속염 또는 알콜이나 클로르헤시딘(chlorhexidine)과 같은 소독제를 사용하였다. 그러나, 이러한 금속염이나 소독제는 구취를 발생시키는 혐기성 세균뿐만 아니라 구강내 다른 미생물까지도 발생을 억제하며, 이러한 물질은 식도로 삼키지 않기 때문에 구취 발생에 있어서 중요한 장소인 혀의 뒷쪽까지 가지 못하고 구강 앞쪽에서 주로 가글링되고 입밖으로 뱉어내어 진다. 그래서, 구취 발생 혐기성 세균의 주요한 증식 장소인 혀 뒤쪽까지는 소독할 수 없다는 문제점이 있다. 또한, 이러한 물질은 타액에 의해서 희석되고 타액과 함께 식도로 삼켜져 구강에서의 효과는 20분 내지 2시간 정도뿐이고, 그 후 구강에는 미생물이 다시 증식하여 구취가 발생하게 된다. 따라서, 구취를 감소시키기 위하여 사용되고 있는 금속염이나 소독제는 그 효과가 단기간에 불과하고, 구취 재발이 빈번하다.Bad breath refers to the odor originating from the oral cavity and adjacent organs, and many people complain of bad breath in their daily lives. 85-90% of bad breath originates in the oral cavity, particularly the back of the tongue. The main components of bad breath are volatile sulfur compounds, of which 90% are hydrogen sulfide, derived from cysteine, and methyl mercaptan and dimethyl sulfide, derived from methionine. These compounds are primarily produced by protein enzymes secreted by anaerobic bacteria, and the back of the tongue is a prime habitat for them. This area is poorly cleansed by saliva and contains numerous small depressions, creating a persistent habitat for bacteria. While the production of volatile sulfur compounds by anaerobic bacteria is the primary cause of bad breath, oral diseases such as caries and periodontitis can also contribute to its occurrence. Many types of anaerobic bacteria are involved in causing bad breath, but in particular, the representative bacteria causing bad breath are Porphyromonas gingivalis , Prevotella intermedia , Fusobacterium nucleatum , Bacteoides forsythus , and Treponema deticola , which secrete many types and large amounts of enzymes, and are also known as representative causative bacteria of periodontitis. In order to suppress bad breath, the most effective way is to suppress the growth of anaerobic bacteria that produce volatile sulfur compounds, the main component of bad breath. Therefore, in the past, tongue scrapers were used to remove tongue coating to remove the growth substrate for bacteria from the tongue, or metal salts such as zinc chloride or disinfectants such as alcohol or chlorhexidine were used to suppress the growth of anaerobic bacteria or the production of volatile sulfur compounds by anaerobic bacteria. However, these metal salts and disinfectants suppress not only the anaerobic bacteria that cause bad breath but also other microorganisms in the oral cavity. Since these substances are not swallowed into the esophagus, they do not reach the back of the tongue, which is a key site for bad breath, but are mainly gargled at the front of the mouth and spit out. Therefore, there is a problem in that the back of the tongue, which is the main site of proliferation of anaerobic bacteria that cause bad breath, cannot be disinfected. Furthermore, these substances are diluted by saliva and swallowed through the esophagus. Their oral effects last only about 20 minutes to two hours, after which time microorganisms proliferate again, causing bad breath. Therefore, metal salts and disinfectants used to reduce bad breath have only short-term effects, and recurrence of bad breath is frequent.

치약은 치아의 표면을 잇솔질할 때 사용하는 의약부외품으로서, 특히 미백효과, 살균효과, 치간청정효과 등을 목적으로 주로 사용하며, 이를 위하여 일반적으로 치약은 연마제, 습윤제, 기포제, 감미제와 같은 성분들을 포함하여 이루어진다. 최근에는 충치, 치주염, 구취 억제 효과를 개선하기 위한 다양한 기능성 치약의 제조를 위한 연구가 많이 진행되고 있다. 게다가 최근에 치주 질환은 단순한 잇몸 조직의 만성 감염에 그치지 않고, 심근경색, 동맥경화를 비롯하여 당뇨병, 조산(早産) 유발 등의 위험인자로서 주목을 받고 있다. 따라서 치약 사용이 각종 건강 상태를 호전시킬 수 있는 기반이 될 가능성을 암시하기도 한다. 한편, 일반적으로 충치나 치주염을 예방하기 위해 치약이나 구강청정제에 0.05~0.1. w/v% 농도의 불소가 자주 사용되는데, 최근의 보고에 의하면 치약이나 구강청정제 등에서 불소화합물의 사용이 치아의 우식증은 예방할 수는 있지만, 장기적이고 반복적인 불소화합물 사용은 잇몸에 염증 현상을 촉진하는 것으로 밝혀지고 있다. 따라서, 불소를 사용하지 않으면서도 시린 이 현상을 억제하고 치아 우식증을 예방할 수 있는 치약 조성물이 요구되고 있다. Toothpaste is a quasi-drug used to brush the surface of teeth. It is primarily used for whitening, sterilizing, and interdental cleaning effects. To achieve these effects, toothpaste typically contains ingredients such as abrasives, humectants, foaming agents, and sweeteners. Recently, extensive research has been conducted to develop various functional toothpastes to improve the effects of tooth decay, periodontitis, and bad breath. Furthermore, periodontal disease is not simply a chronic infection of the gum tissue, but is also gaining attention as a risk factor for myocardial infarction, arteriosclerosis, diabetes, and premature birth. Therefore, toothpaste use may serve as a foundation for improving various health conditions. Meanwhile, to prevent tooth decay and periodontitis, toothpaste or mouthwash typically contains 0.05-0.1% of the total active ingredient. Fluoride is frequently used at concentrations of w/v%. Recent reports have shown that while the use of fluoride compounds in toothpaste and mouthwashes can prevent dental caries, long-term and repeated use of fluoride compounds promotes gingival inflammation. Therefore, there is a need for a toothpaste composition that can suppress tooth sensitivity and prevent dental caries without using fluoride.

이에 본 발명자들은 치태와 백태(설태) 같은 프라그 제거가 우수하여 치석 방지 효능이 좋고, 항균/소취 효능이 뛰어난 각종 천연물 추출물이 포함된 조성물을 거품치약의 원료로 이용함으로써 위생적인 구강 환경을 유지할 수 있음이 확인하여 본 발명을 완성하였다. Accordingly, the inventors of the present invention have confirmed that a hygienic oral environment can be maintained by using a composition containing various natural extracts that are excellent in removing plaque such as dental plaque and white coating (tongue coating), have excellent anti-tartar effect, and have excellent antibacterial/deodorizing effect as a raw material for foam toothpaste, thereby completing the present invention.

대한민국 등록특허 제10-2196459호 (발명의 명칭 : 항균 성능이 개선된 치약 조성물 및 이를 포함하는 치약, 출원인 : 주식회사 메디덴코, 등록일 : 2020년12월22일)Republic of Korea Patent No. 10-2196459 (Title of invention: Toothpaste composition with improved antibacterial performance and toothpaste containing the same, Applicant: Medidenko Co., Ltd., Registration date: December 22, 2020) 대한민국 등록특허 제10-1841181호 (발명의 명칭 : 생약 추출물을 함유하는 치약 조성물, 출원인 : 셀포원(주), 등록일 : 2018년03월16일)Republic of Korea Patent No. 10-1841181 (Title of invention: Toothpaste composition containing herbal extract, Applicant: Cellpoone Co., Ltd., Registration date: March 16, 2018)

본 발명의 목적은 녹차 추출물, 오미자 추출물, 상추 추출물, 콜라비 추출물, 카렌듈라 추출물, 삼칠 추출물, 작약 추출물, 짚신나물 추출물, 흑미강 추출물 및 땅콩 추출물을 포함하여, 치태 및 백태와 같은 프라그 제거 효능, 치석 예방, 구취 제거, 항균 효능을 갖는 거품 치약 조성물을 제공하는 데에 있다. The purpose of the present invention is to provide a foaming toothpaste composition having plaque removal effects such as dental plaque and white plaque prevention, bad breath removal, and antibacterial effects, including green tea extract, Schisandra chinensis extract, lettuce extract, kohlrabi extract, calendula extract, ginseng extract, peony extract, aster extract, black rice bran extract, and peanut extract.

본 발명은 녹차 추출물, 오미자 추출물, 상추 추출물, 콜라비 추출물, 카렌듈라 추출물, 삼칠 추출물, 작약 추출물, 짚신나물 추출물, 흑미강 추출물 및 땅콩 추출물을 포함하는 거품 치약 조성물에 관한 것이다. The present invention relates to a foaming toothpaste composition comprising a green tea extract, a Schisandra chinensis extract, a lettuce extract, a kohlrabi extract, a calendula extract, a ginseng extract, a peony extract, a straw flower extract, a black rice bran extract, and a peanut extract.

상기 조성물은 항균 효능이 있는 것을 특징으로 한다. 바람직하게는 상기 조성물은 구강 내 세균인 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대한 항균 효능이 있는 것을 특징으로 한다. The composition is characterized by having antibacterial efficacy. Preferably, the composition is characterized by having antibacterial efficacy against Streptococcus mutans, an oral bacterium.

또는 상기 조성물은 구취 제거 효능을 갖는 것을 특징으로 한다. 바람직하게는 구취 유발균인 포르피로모나스 진지발리스(Porphyromonas gingivalis)에 대한 항균 효능이 있는 것을 특징으로 한다. Or, the composition is characterized by having a bad breath removal effect. Preferably, it is characterized by having an antibacterial effect against Porphyromonas gingivalis , a bad breath-causing bacteria.

상기 조성물은 바람직하게는 녹차 추출물 100 중량부 기준으로, 오미자 추출물 30~70 중량부, 상추 추출물 120~160 중량부, 콜라비 추출물 190~230 중량부, 카렌듈라 추출물 10~50 중량부, 삼칠 추출물 30~70 중량부, 작약 추출물 20~40 중량부, 짚신나물 추출물 40~60 중량부, 흑미강 추출물 10~30 중량부 및 땅콩 추출물 40~60 중량부를 함유할 수 있다. The composition may preferably contain 30 to 70 parts by weight of Schisandra chinensis extract, 120 to 160 parts by weight of lettuce extract, 190 to 230 parts by weight of kohlrabi extract, 10 to 50 parts by weight of calendula extract, 30 to 70 parts by weight of Samchil extract, 20 to 40 parts by weight of peony extract, 40 to 60 parts by weight of agarwood extract, 10 to 30 parts by weight of black rice bran extract, and 40 to 60 parts by weight of peanut extract, based on 100 parts by weight of green tea extract.

상기 조성물은 프라그 제거로 인한 치석 형성을 방지하는 것을 특징으로 한다. The above composition is characterized by preventing tartar formation due to plaque removal.

또한 상기 조성물에는 제형 안정화 및 프라그 제거 효능을 높이기 위해, 플루오르화나트륨, 벤조산나트륨, 구연산, 글리세린, 라우로일사르코신나트륨, 스테비올배당체, 염화나트륨, 자일리톨, 코코일글루타민산나트륨, 탄산수소나트륨, 토코페롤아세테이트, 하이드로제네이티드캐스터오일, 글루콘산나트륨, 알란토인, 시트르산나트륨, 글루콘산아연, 향료 및 정제수가 포함될 수 있다. In addition, the composition may include sodium fluoride, sodium benzoate, citric acid, glycerin, sodium lauroyl sarcosine, steviol glycosides, sodium chloride, xylitol, sodium cocoyl glutamate, sodium bicarbonate, tocopheryl acetate, hydrogenated castor oil, sodium gluconate, allantoin, sodium citrate, zinc gluconate, fragrance, and purified water to enhance formulation stabilization and plaque removal efficacy.

바람직하게는 플루오르화나트륨 1000~1400 중량부, 벤조산나트륨 3000~6000 중량부, 구연산 400~600 중량부, 글리세린 60000~100000 중량부, 라우로일사르코신나트륨 3000~6000 중량부, 스테비올배당체 1500~4000 중량부, 염화나트륨 1000~1200 중량부, 자일리톨 3000~7000 중량부, 코코일글루타민산나트륨 5000~9000 중량부, 탄산수소나트륨 10000~30000 중량부, 토코페롤아세테이트 5~30 중량부, 하이드로제네이티드캐스터오일 10000~30000 중량부, 소르빈산칼륨 50~200 중량부, 글루콘산나트륨 200~500 중량부, 알란토인 50~150 중량부, 시트르산나트륨 200~350 중량부, 글루콘산아연 100~300 중량부, 향료 2000~5000 중량부 및 정제수 500000~1000000 중량부가 포함될 수 있다. Preferably, 1000 to 1400 parts by weight of sodium fluoride, 3000 to 6000 parts by weight of sodium benzoate, 400 to 600 parts by weight of citric acid, 60,000 to 100,000 parts by weight of glycerin, 3000 to 6000 parts by weight of sodium lauroyl sarcosine, 1500 to 4000 parts by weight of steviol glycoside, 1000 to 1200 parts by weight of sodium chloride, 3000 to 7000 parts by weight of xylitol, 5000 to 9000 parts by weight of sodium cocoyl glutamate, 10,000 to 30,000 parts by weight of sodium bicarbonate, 5 to 30 parts by weight of tocopherol acetate, 10,000 to 30,000 parts by weight of hydrogenated castor oil, 50 to 200 parts by weight of potassium sorbate, It may contain 200 to 500 parts by weight of sodium gluconate, 50 to 150 parts by weight of allantoin, 200 to 350 parts by weight of sodium citrate, 100 to 300 parts by weight of zinc gluconate, 2000 to 5000 parts by weight of fragrance, and 500,000 to 1,000,000 parts by weight of purified water.

이하, 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.

본 발명의 거품 치약 조성물은 칫솔을 사용하는 구강 양치질에 적용할 수 있으며, 특히, 펌프 용기에 담겨 거품 상태로 토출되기에 적합한 제형으로 제조되기 때문에, 혀 안쪽에 미세한 솔을 가하여 백태(설태)를 제거하는 백태 제거용 치약으로도 이용가능하다. 또한, 구강 내 삽입하는 다양한 구강 보조기들의 세정에 상기 거품치약 조성물을 적용하여 세정할 수도 있다. The foam toothpaste composition of the present invention can be applied to oral brushing using a toothbrush, and in particular, since it is manufactured in a formulation suitable for being dispensed in a foam state by being contained in a pump container, it can also be used as a toothpaste for removing white coating (tongue coating) by applying a fine brush to the inside of the tongue. In addition, the foam toothpaste composition can be applied to clean various oral orthodontic devices inserted into the oral cavity.

상기 조성물 내 추출물은 원료 시료를 물, C1~C4 알코올 또는 이들의 혼합용액을 용매로 하여 추출할 수 있으며, 상기 C1~C4 알코올은 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 및 이소부탄올로 이루어진 군에서 선택될 수 있다. 상기 추출물은 또한 30~90%(v/v) 알코올 수용액 추출물, 바람직하게는 50~80%(v/v) 알코올 수용액 추출물일 수 있다. The extract in the above composition can be extracted from a raw material sample using water, C1-C4 alcohol, or a mixed solution thereof as a solvent, and the C1-C4 alcohol can be selected from the group consisting of methanol, ethanol, propanol, isopropanol, butanol, and isobutanol. The extract can also be a 30-90% (v/v) alcohol aqueous solution extract, preferably a 50-80% (v/v) alcohol aqueous solution extract.

상기 추출물의 제조시 사용되는 물, C1~C4 알코올 또는 이들의 혼합용액은 원료시료 사용 중량 기준 1~40배 부피(1kg 기준 1~40ℓ)를 사용할 수 있으며, 바람직하게는 5~40배 부피를 사용할 수 있다. 상기 추출물의 추출조건은 20~100℃에서 1분~48시간일 수 있다. 상기 과정은 1~4번까지 반복할 수 있다. The water, C1~C4 alcohol or a mixed solution thereof used in the production of the above extract may be used in an amount of 1~40 times the volume based on the weight of the raw material sample used (1~40 ℓ per 1 kg), and preferably 5~40 times the volume may be used. The extraction conditions of the above extract may be 20~100℃ for 1 minute~48 hours. The above process may be repeated 1~4 times.

또한, 당분야의 통상적인 방법으로서 상기 원료시료의 물, C1~C4 알코올 또는 이들의 혼합용액 추출물을 물에 녹인 후에 n-헥산, 메틸렌클로라이드, 아세톤, 클로로포름, 에틸아세테이트 및 n-부탄올로 이루어진 군 중에서 선택되는 1종 이상의 용매를 사용하여 추가적으로 분획하여 분획물로 제조할 수 있다. In addition, as a conventional method in the field, the raw material sample's water, C1~C4 alcohol or mixed solution extract thereof is dissolved in water, and then further fractionated using at least one solvent selected from the group consisting of n-hexane, methylene chloride, acetone, chloroform, ethyl acetate and n-butanol, thereby producing a fraction.

상기 추출물 또는 이의 분획물의 제조온도는 20 내지 100℃일 수 있으나, 이에 제한되는 것은 아니다. 추출 또는 분획 시간은 특별히 제한되는 것은 아니나, 10분 내지 2일 이내에 추출하는 것이 바람직하며, 추출용 기기로는 통상의 추출기기, 초음파분쇄추출기 또는 분획기를 이용할 수 있다. 이렇게 제조된 추출물 또는 분획물은 열풍건조, 감압건조 또는 동결건조하여 용매를 제거할 수 있다. The temperature at which the extract or fraction thereof is prepared may be, but is not limited to, 20 to 100°C. The extraction or fractionation time is not particularly limited, but it is preferable to extract within 10 minutes to 2 days. A conventional extraction device, an ultrasonic grinding extractor, or a fractionator may be used as the extraction device. The extract or fraction prepared in this manner may be subjected to hot air drying, reduced pressure drying, or freeze drying to remove the solvent.

상기 향료로는 치약에 적용될 수 있는 통상의 다양한 과일 향료 또는 허브 향료를 사용할 수 있다. 바람직하게는, 자몽, 레몬, 포도, 녹차, 딸기, 바나나, 페퍼민트, 열대과일 등의 향료를 사용할 수 있다. 상기 스테비올배당체는 스테비아 추출물에서 분리된 통상적으로 이용되는 식품용 대체감미제(FDA(미국 식품의약국)와 EFSA(유럽 식품안전처)에서 인정된 인공감미료)이다. The above-mentioned flavoring agent may be a variety of common fruit or herbal flavorings applicable to toothpaste. Preferably, flavoring agents such as grapefruit, lemon, grape, green tea, strawberry, banana, peppermint, and tropical fruits can be used. The steviol glycoside is a commonly used food alternative sweetener (an artificial sweetener approved by the FDA (US Food and Drug Administration) and EFSA (European Food Safety Authority)) isolated from stevia extract.

본 발명은 녹차 추출물, 오미자 추출물, 상추 추출물, 콜라비 추출물, 카렌듈라 추출물, 삼칠 추출물, 작약 추출물, 짚신나물 추출물, 흑미강 추출물 및 땅콩 추출물을 포함하는 거품 치약 조성물에 관한 것이다. 천연물로부터 얻은 원료가 포함된 상기 거품 치약 조성물은 스트렙토코쿠스 뮤탄스(Streptococcus mutans), 포르피로모나스 진지발리스(Porphyromonas gingivalis) 등의 구강 내 세균에 항균 효능 및 구취 제거 효능이 있으며, 구강 내 잇몸에 프라그 제거 효능이 우수하여 치석이 쌓이는 것을 방지하는 기능이 뛰어나다. 이에 상기 거품 치약 조성물을 사용함으로써 보다 위생적이고 청결한 구강 관리를 할 수 있게 한다. The present invention relates to a foaming toothpaste composition comprising a green tea extract, a Schisandra chinensis extract, a lettuce extract, a kohlrabi extract, a calendula extract, a Samchil extract, a peony extract, a Agrimonia japonica extract, a black rice bran extract, and a peanut extract. The foaming toothpaste composition comprising raw materials obtained from natural products has an antibacterial effect against oral bacteria such as Streptococcus mutans and Porphyromonas gingivalis and an effect of eliminating bad breath, and has an excellent effect of removing plaque from the gums in the oral cavity, thereby having an excellent function of preventing tartar build-up. Therefore, by using the foaming toothpaste composition, more hygienic and clean oral care can be achieved.

이하 본 발명의 바람직한 실시예를 상세히 설명하기로 한다. 그러나, 본 발명은 여기서 설명되는 실시예에 한정되지 않고 다른 형태로 구체화될 수도 있다. 오히려, 여기서 소개되는 내용이 철저하고 완전해지도록, 당업자에게 본 발명의 사상을 충분히 전달하기 위해 제공하는 것이다. Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the embodiments described herein and may be embodied in other forms. Rather, the contents introduced herein are provided to ensure thoroughness and completeness, and to sufficiently convey the spirit of the present invention to those skilled in the art.

<실시예 1 내지 8. 천연물 혼합 추출물을 포함하는 원료 조성물 및 이를 포함하는 거품 치약 제형의 제조><Examples 1 to 8. Preparation of a raw material composition containing a natural product mixture extract and a foam toothpaste formulation containing the same>

녹차 추출물, 오미자 추출물, 상추 추출물, 콜라비 추출물, 카렌듈라 추출물, 삼칠 추출물, 작약 추출물, 짚신나물 추출물, 흑미강 추출물 및 땅콩 추출물을 제조하고 혼합하여 표 1과 같이 실시예 1 내지 3의 치약 조성물용 천연물 추출물의 혼합물을 제조하였다. Green tea extract, Schisandra chinensis extract, lettuce extract, kohlrabi extract, calendula extract, Samchil extract, peony extract, aster extract, black rice bran extract, and peanut extract were prepared and mixed to prepare a mixture of natural extracts for toothpaste compositions of Examples 1 to 3 as shown in Table 1.

이후, 부형제들로서, 플루오르화나트륨, 벤조산나트륨, 구연산, 글리세린, 라우로일사르코신나트륨, 스테비올배당체, 염화나트륨, 자일리톨, 코코일글루타민산나트륨, 탄산수소나트륨, 토코페롤아세테이트, 하이드로제네이티드캐스터오일, 소르빈산칼륨, 글루콘산나트륨, 알란토인, 시트르산나트륨, 글루콘산아연, 알란토인, 향료 및 정제수를 원료로 준비하여 표 1에서 제조한 실시예 1 내지 3의 조성물에 혼합하여 표 2의 실시예 4 내지 6에 개시한 것과 같은 치약 조성물로 제조하였다. Afterwards, excipients such as sodium fluoride, sodium benzoate, citric acid, glycerin, sodium lauroyl sarcosine, steviol glycosides, sodium chloride, xylitol, sodium cocoyl glutamate, sodium bicarbonate, tocopheryl acetate, hydrogenated castor oil, potassium sorbate, sodium gluconate, allantoin, sodium citrate, zinc gluconate, allantoin, fragrance, and purified water were prepared as raw materials and mixed with the compositions of Examples 1 to 3 prepared in Table 1 to prepare toothpaste compositions as disclosed in Examples 4 to 6 of Table 2.

실시예 3의 원료에 부형제 혼합비를 달리한 것은 표 2와 같이 실시예 7과 실시예 8 조성물로 제조하였다. The raw material of Example 3 was mixed with different excipients to produce the compositions of Example 7 and Example 8 as shown in Table 2.

이 중에서, 실시예 4 내지 8의 조성물은 용기에서 토출될 때 거품이 형성되어 나오는 노즐이 내장된 펌프 용기에 주입하여 최종 제형화하였다. Among these, the compositions of Examples 4 to 8 were injected into a pump container equipped with a nozzle that forms foam when discharged from the container, thereby forming a final formulation.

(즉, 표 1은 천연물 원료의 항균능을 보다 효과적으로 확인하기 위해 별도로 제시한 것이며, 표 2는 이 천연물 원료에 항균능의 지속/유지용 제형화를 위해 최적의 조건을 제시한 예시이다.) (That is, Table 1 is presented separately to more effectively confirm the antibacterial activity of natural raw materials, and Table 2 is an example that presents the optimal conditions for formulation to sustain/maintain the antibacterial activity of this natural raw material.)

원료로 사용된 각 추출물은 70%(v/v) 에탄올 수용액을 10배 중량을 가하여 60℃에서 8시간 동안 추출하여 얻은 액상을 감압농축 및 동결건조하여 제조한 것이고, 그 외의 원료는 통상의 식품 또는 구강 세정제용 원료로 사용되는 것들을 구매하여 사용하였다. Each extract used as a raw material was prepared by adding 10 times the weight of a 70% (v/v) ethanol aqueous solution and extracting the obtained liquid at 60°C for 8 hours, and then concentrating under reduced pressure and freeze-drying the resulting liquid. Other raw materials were purchased and used as raw materials for common foods or oral cleansers.

중량부Weight division 실시예 1Example 1 실시예 2Example 2 실시예 3Example 3 녹차 추출물 green tea extract 100100 100100 100100 오미자 추출물 Schisandra chinensis extract 3030 7070 5050 상추 추출물 lettuce extract 160160 120120 150150 콜라비 추출물 Kohlrabi extract 190190 230230 200200 카렌듀라 추출물 Calendula extract 5050 1010 3030 삼칠 추출물Samchil extract 7070 3030 5050 작약 추출물Peony extract 2020 4040 3030 짚신나물 추출물Strawberry extract 4040 6060 5050 흑미강 추출물Black rice extract 3030 1010 2020 땅콩 추출물peanut extract 4040 6060 5050 소계subtotal 730730 730730 730730

원료 / 중량부Raw materials / parts by weight 실시예 4Example 4 실시예 5Example 5 실시예 6Example 6 실시예 7Example 7 실시예 8Example 8 녹차 추출물 green tea extract 100100 100100 100100 100100 100100 오미자 추출물 Schisandra chinensis extract 3030 7070 5050 5050 5050 상추 추출물 lettuce extract 160160 120120 150150 150150 150150 콜라비 추출물 Kohlrabi extract 190190 230230 200200 200200 200200 카렌듀라 추출물 Calendula extract 5050 1010 3030 3030 3030 삼칠 추출물Samchil extract 7070 3030 5050 5050 5050 작약 추출물Peony extract 2020 4040 3030 3030 3030 짚신나물 추출물Strawberry extract 4040 6060 5050 5050 5050 흑미강 추출물Black rice extract 3030 1010 2020 2020 2020 땅콩 추출물peanut extract 4040 6060 5050 5050 5050 플루오르화나트륨sodium fluoride 10001000 10001000 10001000 14001400 11001100 벤조산나트륨sodium benzoate 40004000 40004000 40004000 60006000 30003000 구연산citric acid 400400 400400 400400 600600 500500 글리세린glycerin 100000100000 100000100000 100000100000 6000060000 100000100000 라우로일사르코신나트륨 sodium lauroyl sarcosine 60006000 60006000 60006000 40004000 30003000 스테비올배당체 Steviol glycosides 40004000 40004000 40004000 15001500 20002000 염화나트륨 sodium chloride 12001200 12001200 12001200 11001100 10001000 자일리톨 Xylitol 30003000 30003000 30003000 70007000 50005000 코코일글루타민산나트륨Monosodium cocoyl glutamate 70007000 70007000 70007000 90009000 50005000 탄산수소나트륨 sodium bicarbonate 1400014000 1400014000 1400014000 3000030000 1000010000 토코페롤아세테이트Tocopheryl acetate 1010 1010 1010 1010 1010 하이드로제네이티드캐스터오일Hydrogenated Castor Oil 1000010000 1000010000 1000010000 3000030000 2000020000 소르빈산칼륨potassium sorbate 5050 5050 5050 200200 100100 글루콘산나트륨sodium gluconate 300300 300300 300300 200200 500500 알란토인Allantoin 150150 150150 150150 5050 100100 시트르산나트륨sodium citrate 200200 200200 200200 350350 200200 글루콘산아연zinc gluconate 300300 300300 300300 200200 100100 향료 spices 30003000 30003000 30003000 30003000 30003000 정제수 purified water 800000800000 800000800000 800000800000 800000800000 800000800000 합계total 955340955340 955340955340 955340955340 955340 955340 955340 955340

<비교예 1 내지 6. 비교용 조성물의 제조><Comparative Examples 1 to 6. Preparation of Comparative Compositions>

실시예 1에서 치약 조성물 제조에 사용된 각 원료를 사용하여 표 3과 같이 비교용 원료 추출물의 혼합 조성물인 비교예 1 내지 3의 조성물을 제조하였다. Using each raw material used in the manufacture of the toothpaste composition in Example 1, compositions of Comparative Examples 1 to 3, which are mixed compositions of comparative raw material extracts, were manufactured as shown in Table 3.

상기 비교예 1 내지 3의 조성물이 제형화 되었을 때의 치약의 상태를 확인하기 위해서 표 4와 같이 비교예 4 내지 6의 조성물을 제조하였고, 각 부형제의 최적 조건을 확인하기 위해 비교예 7 내지 9와 같은 조성물도 제조하였다. 상기 비교예 4 내지 9의 조성물 역시 거품이 형성되는 펌프에 주입하여 제형화하였다. In order to confirm the condition of the toothpaste when the compositions of Comparative Examples 1 to 3 were formulated, the compositions of Comparative Examples 4 to 6 were prepared as shown in Table 4, and in order to confirm the optimal conditions of each excipient, the compositions of Comparative Examples 7 to 9 were also prepared. The compositions of Comparative Examples 4 to 9 were also formulated by injecting them into a pump that forms foam.

중량부Weight division 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 녹차 추출물 green tea extract 100100 100100 100100 오미자 추출물 Schisandra chinensis extract 200200 00 9090 상추 추출물 lettuce extract 150150 00 5050 콜라비 추출물 Kohlrabi extract 150150 00 5050 카렌듀라 추출물 Calendula extract 00 100100 100100 삼칠 추출물Samchil extract 00 200200 100100 작약 추출물Peony extract 00 130130 100100 짚신나물 추출물Strawberry extract 130130 00 2020 흑미강 추출물Black rice extract 00 100100 100100 땅콩 추출물peanut extract 00 100100 2020 합계total 730730 730730 730730

중량부Weight division 비교예 4Comparative Example 4 비교예 5Comparative Example 5 비교예 6Comparative Example 6 비교예 7Comparative Example 7 비교예 8Comparative Example 8 비교예 9Comparative Example 9 녹차 추출물 green tea extract 100100 100100 100100 100100 100100 100100 오미자 추출물 Schisandra chinensis extract 200200 00 9090 5050 5050 5050 상추 추출물 lettuce extract 150150 00 5050 150150 150150 150150 콜라비 추출물 Kohlrabi extract 150150 00 5050 200200 200200 200200 카렌듀라 추출물 Calendula extract 00 100100 100100 3030 3030 3030 삼칠 추출물Samchil extract 00 200200 100100 5050 5050 5050 작약 추출물Peony extract 00 130130 100100 3030 3030 3030 짚신나물 추출물Strawberry extract 130130 00 2020 5050 5050 5050 흑미강 추출물Black rice extract 00 100100 100100 2020 2020 2020 땅콩 추출물peanut extract 00 100100 2020 5050 5050 5050 플루오르화나트륨sodium fluoride 10001000 10001000 10001000 11001100 11001100 11001100 벤조산나트륨sodium benzoate 40004000 40004000 40004000 10001000 1500015000 1000010000 구연산citric acid 400400 400400 400400 500500 00 10001000 글리세린glycerin 100000100000 100000100000 100000100000 9000090000 100000100000 3000030000 라우로일사르코신나트륨 sodium lauroyl sarcosine 60006000 60006000 60006000 80008000 00 80008000 스테비올배당체 Steviol glycosides 40004000 40004000 40004000 00 40004000 10001000 염화나트륨 sodium chloride 12001200 12001200 12001200 10001000 00 500500 자일리톨 Xylitol 30003000 30003000 30003000 00 10001000 10001000 코코일글루타민산나트륨Monosodium cocoyl glutamate 70007000 70007000 70007000 1000010000 1400014000 1200012000 탄산수소나트륨 sodium bicarbonate 1400014000 1400014000 1400014000 2000020000 1700017000 40004000 토코페롤아세테이트Tocopheryl acetate 1010 1010 1010 1010 00 6060 하이드로제네이티드캐스터오일Hydrogenated Castor Oil 1000010000 1000010000 1000010000 2000020000 00 4400044000 소르빈산칼륨potassium sorbate 5050 5050 5050 00 170170 10001000 글루콘산나트륨sodium gluconate 300300 300300 300300 00 340340 100100 알란토인Allantoin 150150 150150 150150 100100 00 250250 시트르산나트륨sodium citrate 200200 200200 200200 200200 00 500500 글루콘산아연zinc gluconate 300300 300300 300300 00 00 100100 향료 spices 30003000 30003000 30003000 27002700 20002000 4000040000 정제수 purified water 800000800000 800000800000 800000800000 800000800000 800000800000 800000800000 합계total 955340955340 955340955340 955340955340 955340955340 955340955340 955340955340

<실험예 1. 항균 효과 확인><Experimental Example 1. Confirmation of Antibacterial Effect>

제조되어 실온에서 6개월간 보관된 실시예 1 내지 3, 비교예 1 내지 3의 조성물을 DMSO(Dimethyl sulfoxide)에 용해하고, 이를 PBS(Phosphate-buffered saline) 로 희석하여 스트렙토코쿠스 뮤탄스(Streptococcus mutans)와 포르피로모나스 진지발리스(Porphyromonas gingivalis)의 구강 세균에 대한 항균 효과를 확인하였다. The compositions of Examples 1 to 3 and Comparative Examples 1 to 3, which were manufactured and stored at room temperature for 6 months, were dissolved in DMSO (Dimethyl sulfoxide), diluted with PBS (Phosphate-buffered saline), and the antibacterial effect against oral bacteria such as Streptococcus mutans and Porphyromonas gingivalis was confirmed.

이 구강 세균들을 헤민 메나디온(hemin menadione)이 첨가된 TSA(trypticase soy agar) 배지에 배양한 후, 최소생육억제농도(MIC)를 측정하였고 이를 표 5에 나타내었다. 이 때, 각 조성물은 최종 농도가 1000 ㎍/㎖ 이하가 되도록 희석하였고, 각 균주(세균)는 O.D.600 = 0.2로 농도를 조절하여 사용하였다. 96-웰 플레이트(96-well plate, Falcon, USA)에 본 발명에 사용된 세균 배양용 헤민 메나디온이 첨가된 TSB(trypticase soy broth) 100 ㎖, 각 조성물 희석 용액 50 ㎖, 균주 희석액 50 ㎖를 순차적으로 첨가한 뒤 4 시간마다 UV-스펙트로포토미터(spectrophotometer)를 이용해 흡광도 값을 측정하면서 24 시간 동안 37 ℃에서 배양하였다. 이때, 세균의 생육 곡선상에서 균주의 생장(turbidity)이 검출되지 않는 최소농도를 최소생육억제농도로 설정하였다.These oral bacteria were cultured on trypticase soy agar (TSA) medium supplemented with hemin menadione, and the minimum inhibitory concentration (MIC) was measured, which is shown in Table 5. At this time, each composition was diluted to a final concentration of 1000 ㎍/㎖ or less, and each strain (bacteria) was used by adjusting the concentration to O.D.600 = 0.2. 100 ml of trypticase soy broth (TSB) supplemented with hemin menadione for bacterial culture used in the present invention, 50 ml of each composition dilution solution, and 50 ml of strain dilution solution were sequentially added to a 96-well plate (96-well plate, Falcon, USA), and then cultured at 37°C for 24 hours while measuring the absorbance value every 4 hours using a UV spectrophotometer. At this time, the minimum concentration at which no growth (turbidity) of the strain was detected on the bacterial growth curve was set as the minimum growth inhibitory concentration.

조건condition 스트렙토코쿠스 뮤탄스에 관한
MIC (㎍/㎖)
About Streptococcus mutans
MIC (㎍/㎖)
포르피로모나스 진지발리스에 관한
MIC (㎍/㎖)
About Porphyromonas gingivalis
MIC (㎍/㎖)
실시예 1Example 1 1.21.2 1.21.2 실시예 2Example 2 13.213.2 13.113.1 실시예 3Example 3 15.215.2 16.316.3 비교예 1Comparative Example 1 112.3112.3 112.1112.1 비교예 2Comparative Example 2 98.198.1 109.2109.2 비교예 3Comparative Example 3 123.2123.2 102.4102.4

상기 표 5의 결과를 참고하면 본 발명의 실시예 1 내지 3의 조성물이 갖는 구강내 세균에 대한 항균 효과가 비교예 1 내지 3의 조성물에 비해 현저하게 우수함을 알 수 있다. Referring to the results in Table 5 above, it can be seen that the antibacterial effect against oral bacteria of the compositions of Examples 1 to 3 of the present invention is significantly superior to that of the compositions of Comparative Examples 1 to 3.

<실험예 2. 제형 안정화 확인><Experimental Example 2. Confirmation of Formulation Stability>

구강장치 세정용 조성물이 항균효능을 장기간 유지하면서 안정적으로 사용되기 위해서 제형화하기에 적합한 각 부형제의 성분 및 함량을 확인하였다. 이를 위해 추출물은 동일하되, 부형제 함량이 다른 실시예 6~8, 비교예 7~9의 조성물에 대해 고온 조건인 45℃, 실온인 25℃, 저온인 4℃에서 8시간 사이클링 방식으로 총 1년간 보관하고, 각 조성물을 100배 희석하였다. To ensure that oral device cleaning compositions maintain antibacterial efficacy for long-term use and are stable, the components and contents of each excipient suitable for formulation were identified. To this end, compositions of Examples 6 to 8 and Comparative Examples 7 to 9, which contained the same extract but differed in excipient contents, were stored for a total of one year under 8-hour cycling conditions at high temperature (45°C), room temperature (25°C), and low temperature (4°C), and each composition was diluted 100-fold.

이 후, 실험예 1에서 배양한 것과 동일하게 배양된 스트렙토코쿠스 뮤탄스(Streptococcus mutans)와 포르피로모나스 진지발리스(Porphyromonas gingivalis)의 배양액 100g 기준 각 조성물 희석액 1g을 첨가하여 24시간 동안 37 ℃에서 배양하여 구강 세균의 생육 저지 활성을 확인하였다. Afterwards, 1g of each diluted composition was added to 100g of the culture solution of Streptococcus mutans and Porphyromonas gingivalis cultured in the same manner as in Experimental Example 1, and the growth inhibition activity of oral bacteria was confirmed by culturing at 37°C for 24 hours.

조건condition 스트렙토코쿠스 뮤탄스에 관한
생육 저지 활성 (%)
About Streptococcus mutans
Growth inhibition activity (%)
포르피로모나스 진지발리스에 관한
생육 저지 활성 (%)
About Porphyromonas gingivalis
Growth inhibition activity (%)
실시예 6Example 6 99.999.9 99.999.9 실시예 7Example 7 99.999.9 99.999.9 실시예 8Example 8 99.999.9 99.999.9 비교예 7Comparative Example 7 21.421.4 19.219.2 비교예 8Comparative Example 8 20.520.5 25.125.1 비교예 9Comparative Example 9 25.125.1 24.324.3

확인 결과, 실시예 6~8의 조성물 희석액이 첨가된 군에서는 각 구강세균의 증식이 거의 나타나지 않았으나, 비교예 7~9는 같은 실시예 1의 추출물에 부형제가 다르게 적용된 것이라는 차이점만 있음에도 불구하고 구강 세균의 증식 억제 효능이 저하된 것으로 나타났다. As a result of the verification, in the group to which the diluted compositions of Examples 6 to 8 were added, the growth of each oral bacteria was hardly observed, but in Comparative Examples 7 to 9, the growth inhibition efficacy of oral bacteria was found to be reduced despite the only difference being that different excipients were applied to the extract of the same Example 1.

<실험예 3. 구취 억제능 확인> <Experimental Example 3. Confirmation of Bad Breath Suppression Ability>

치아 내에 플라그나 치석이 쌓이게 되면, 이는 구취나 충치, 치주염의 원인이 된다. 이에, 단기실험으로서, 각 군당 20~50대의 남/녀 10명의 사람들에게 실시예 4 내지 8 및 비교예 4 내지 6의 치약 조성물을 7일간 양치질 시에 이용하여, 조성물의 사용 전 후과 비교한 구취 억제능을 사용자가 체감되는 정도로 비교하여 5점 타점법으로 나타내게 하였다. (5점:매우좋음, 4점:좋음, 3점:보통, 2점:나쁨, 1점:매우나쁨). When plaque or tartar builds up inside the teeth, it causes bad breath, tooth decay, and periodontitis. Therefore, as a short-term experiment, 10 men and women in their 20s to 50s per group used the toothpaste compositions of Examples 4 to 8 and Comparative Examples 4 to 6 when brushing their teeth for 7 days, and the bad breath suppression ability before and after use of the compositions was compared to the degree perceived by the users, and expressed using a 5-point rating scale. (5 points: very good, 4 points: good, 3 points: average, 2 points: bad, 1 point: very bad).

조건condition 구취 억제능Bad breath suppression ability 실시예 4Example 4 4.04.0 실시예 5Example 5 4.14.1 실시예 6Example 6 4.54.5 실시예 7Example 7 4.64.6 실시예 8Example 8 4.54.5 비교예 4Comparative Example 4 3.13.1 비교예 5Comparative Example 5 3.23.2 비교예 6Comparative Example 6 3.03.0

그 결과, 각 사용자들이 본 발명에서 제조된 조성물의 사용에 매우 만족하고 있는 것을 확인할 수 있다. As a result, it can be confirmed that each user is very satisfied with the use of the composition manufactured in the present invention.

<실험예 5. 치석 형성 억제능 확인> <Experimental Example 5. Confirmation of the ability to inhibit tartar formation>

실험예 3에서 실험한 대상자 중, 실시예 4 및 비교예 6의 치약 사용자를 2명씩을 선별하여, 동일 조성물을 이용하여 스켈링 후, 6개월간 양치질을 수행하게 하였고, 치석이 형성되는 정도와 이에 따른 잇몸의 염증과 붓기 상태, 혀 뿌리 근처에 백태가 형성되는 정도를 스켈링 전과 스켈링 6개월 후로 비교하여 이를 구강검진시 비교하게 하였다. 평가 점수는 검사자(치과의사 및 치위생사)의 육안 검사를 통해 확인하였다. (5점:매우좋음, 4점:좋음, 3점:보통, 2점:나쁨, 1점:매우나쁨).Among the subjects tested in Experimental Example 3, 2 users of the toothpastes of Example 4 and Comparative Example 6 were selected, and the same composition was used for scaling, followed by brushing the teeth for 6 months. The degree of tartar formation, the resulting inflammation and swelling of the gums, and the degree of white coating formation near the root of the tongue were compared before and 6 months after scaling, and compared during an oral examination. The evaluation scores were confirmed through visual inspection by the examiners (dentists and dental hygienists). (5 points: very good, 4 points: good, 3 points: average, 2 points: bad, 1 point: very bad).

조건condition 대상자Target audience 치석 형성
억제 효과
Tartar formation
Inhibitory effect
잇몸 염증/붓기
억제 효과
gum inflammation/swelling
Inhibitory effect
백태 형성
억제 효과
White spot formation
Inhibitory effect
실시예 4Example 4 40대, 여성, 흡연자40s, female, smoker 4.34.3 4.54.5 4.24.2 30대, 남성, 흡연자30s, male, smoker 4.04.0 4.24.2 3.83.8 비교예 6Comparative Example 6 20대, 남성, 흡연자20s, male, smoker 3.23.2 3.13.1 3.23.2 50대, 남성, 흡연자 50s, male, smoker 3.13.1 3.23.2 3.13.1

그 결과, 실시예 4와 비교예 6의 치약을 사용한 사람의 치석 억제 효과 비교시, 실시예 4의 치약 사용자가 6개월 전에 비해, 치석이 형성된 정도가 적고 잇몸의 상태도 매우 양호하였고, 이전에 비해 혀뿌리에 백태(설태)가 적게 형성되는 것을 확인할 수 있었다. 이러한 것을 통해, 본 발명의 치약 조성물이 갖는 프라그 제거 효능이 매우 우수함을 알 수 있다. As a result, when comparing the dental plaque inhibition effects of the toothpastes of Example 4 and Comparative Example 6, it was confirmed that the user of the toothpaste of Example 4 had less dental plaque formed, the condition of the gums was very good, and less white coating (tongue coating) was formed on the tongue root compared to 6 months ago. Through this, it can be seen that the dental plaque removal effect of the toothpaste composition of the present invention is very excellent.

Claims (7)

녹차 추출물 100 중량부, 오미자 추출물 30~70 중량부, 상추 추출물 120~160 중량부, 콜라비 추출물 190~230 중량부, 카렌듈라 추출물 10~50 중량부, 삼칠 추출물 30~70 중량부, 작약 추출물 20~40 중량부, 짚신나물 추출물 40~60 중량부, 흑미강 추출물 10~30 중량부 및 땅콩 추출물 40~60 중량부가 포함된 천연물 추출물의 혼합물;에,
상기 녹차 추출물 100 중량부 기준으로, 플루오르화나트륨 1000~1400 중량부, 벤조산나트륨 3000~6000 중량부, 구연산 400~600 중량부, 글리세린 60000~100000 중량부, 라우로일사르코신나트륨 3000~6000 중량부, 스테비올배당체 1500~4000 중량부, 염화나트륨 1000~1200 중량부, 자일리톨 3000~7000 중량부, 코코일글루타민산나트륨 5000~9000 중량부, 탄산수소나트륨 10000~30000 중량부, 토코페롤아세테이트 5~30 중량부, 하이드로제네이티드캐스터오일 10000~30000 중량부, 소르빈산칼륨 50~200 중량부, 글루콘산나트륨 200~500 중량부, 알란토인 50~150 중량부, 시트르산나트륨 200~350 중량부, 글루콘산아연 100~300 중량부, 향료 2000~5000 중량부 및 정제수 500000~1000000 중량부;가 포함된 항균용 거품 치약 조성물로서,
상기 천연물 추출물의 혼합물이 15.2 ㎍/㎖ 이상의 농도에서 스트렙토코쿠스 뮤탄스(Streptococcus mutans)에 대해 생육 억제 효능을 가지며, 16.3 ㎍/㎖ 이상의 농도에서 포르피로모나스 진지발리스(Porphyromonas gingivalis)에 대해 생육 억제 효능을 갖는 것을 특징으로 하는 항균용 거품 치약 조성물.
A mixture of natural extracts containing 100 parts by weight of green tea extract, 30 to 70 parts by weight of Schisandra chinensis extract, 120 to 160 parts by weight of lettuce extract, 190 to 230 parts by weight of kohlrabi extract, 10 to 50 parts by weight of calendula extract, 30 to 70 parts by weight of Samchil extract, 20 to 40 parts by weight of peony extract, 40 to 60 parts by weight of Apiaceae extract, 10 to 30 parts by weight of black rice bran extract, and 40 to 60 parts by weight of peanut extract;
Based on 100 parts by weight of the above green tea extract, 1000 to 1400 parts by weight of sodium fluoride, 3000 to 6000 parts by weight of sodium benzoate, 400 to 600 parts by weight of citric acid, 60,000 to 100,000 parts by weight of glycerin, 3000 to 6000 parts by weight of sodium lauroyl sarcosine, 1500 to 4000 parts by weight of steviol glycoside, 1000 to 1200 parts by weight of sodium chloride, 3000 to 7000 parts by weight of xylitol, 5000 to 9000 parts by weight of sodium cocoyl glutamate, 10,000 to 30,000 parts by weight of sodium bicarbonate, 5 to 30 parts by weight of tocopherol acetate, 10,000 to 30,000 parts by weight of hydrogenated castor oil, potassium sorbate An antibacterial foam toothpaste composition comprising 50 to 200 parts by weight of sodium gluconate, 200 to 500 parts by weight of allantoin, 200 to 350 parts by weight of sodium citrate, 100 to 300 parts by weight of zinc gluconate, 2000 to 5000 parts by weight of a fragrance, and 500,000 to 1,000,000 parts by weight of purified water;
An antibacterial foam toothpaste composition characterized in that the mixture of the above natural product extracts has a growth inhibitory effect against Streptococcus mutans at a concentration of 15.2 ㎍/㎖ or more and a growth inhibitory effect against Porphyromonas gingivalis at a concentration of 16.3 ㎍/㎖ or more.
제1항에 있어서,
상기 조성물은 구취 억제 효능이 있는 것을 특징으로 하는 항균용 거품 치약 조성물.
In the first paragraph,
The above composition is an antibacterial foam toothpaste composition characterized by having a bad breath suppressing effect.
삭제delete 삭제delete 삭제delete 제1항에 있어서,
상기 조성물은 프라그 제거로 인한 치석 형성을 방지하는 것을 특징으로 하는 항균용 거품 치약 조성물.
In the first paragraph,
The above composition is an antibacterial foam toothpaste composition characterized in that it prevents tartar formation due to plaque removal.
삭제delete
KR1020230070990A 2023-06-01 2023-06-01 Foam toothpaste composition with excellent plaque removal effect Active KR102909306B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020230070990A KR102909306B1 (en) 2023-06-01 2023-06-01 Foam toothpaste composition with excellent plaque removal effect
PCT/KR2023/007817 WO2024248202A1 (en) 2023-06-01 2023-06-08 Foam toothpaste composition having excellent plaque removal effect

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020230070990A KR102909306B1 (en) 2023-06-01 2023-06-01 Foam toothpaste composition with excellent plaque removal effect

Publications (2)

Publication Number Publication Date
KR20240173255A KR20240173255A (en) 2024-12-11
KR102909306B1 true KR102909306B1 (en) 2026-01-09

Family

ID=93657687

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020230070990A Active KR102909306B1 (en) 2023-06-01 2023-06-01 Foam toothpaste composition with excellent plaque removal effect

Country Status (2)

Country Link
KR (1) KR102909306B1 (en)
WO (1) WO2024248202A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070034561A (en) * 2007-03-08 2007-03-28 유홍구 Thought Medicine
BR112013016493A2 (en) * 2011-01-24 2016-09-27 Basf Se use of a binding-ability microorganism or fragment thereof, method of preparing a composition, composition, and, binding-ability microorganism or fragment thereof
KR101841181B1 (en) 2016-09-27 2018-03-22 셀포원(주) Toothpaste composition comprising herval extract
KR102203838B1 (en) * 2017-02-28 2021-01-14 주식회사 엘지생활건강 Pumping type toothpaste composition
KR101955468B1 (en) * 2017-01-31 2019-03-08 농업회사법인 백련동 편백농원 주식회사 Preparing method for toothpaste composition comprising natural extracts
KR102196459B1 (en) 2019-02-15 2020-12-30 주식회사 메디덴코 A toothpaste composition with improved antibacterial performance and a toothpaste comprising the composition
KR102328978B1 (en) * 2020-12-21 2021-11-19 주식회사 신의제약디앤에프 An oral composition for improvement of periodontal disease comprising natural complex extracts

Also Published As

Publication number Publication date
KR20240173255A (en) 2024-12-11
WO2024248202A1 (en) 2024-12-05

Similar Documents

Publication Publication Date Title
Bairwa et al. Traditional medicinal plants: use in oral hygiene
US20090269288A1 (en) Black pearl toothpaste
JP7463429B2 (en) Oral Composition
KR101354923B1 (en) Oral hygiene composition using an extract of curcuma longa and an extract eriobotrya japonica
KR102090119B1 (en) Toothpaste composition comprising herbal extract mixture as effective component
CN107397805B (en) Improve oral hygiene, prevention and the composition and preparation method for the treatment of mouth disease
KR102207872B1 (en) Oral composition for preventation or treatment of oral disease
KR101365352B1 (en) Composition for treating oral disease and inhibiting halitosis comprising the extract of Alder tree
KR101632910B1 (en) Mouth spray composition comprising cypress extracts and medical herb extracts and manufacturing method thereof
KR20140031512A (en) Composition for treating oral disease and inhibiting halitosis comprising the extract of schizandra chinensis
KR102909306B1 (en) Foam toothpaste composition with excellent plaque removal effect
KR102769922B1 (en) Oral care toothpaste composition containing herbal extract
KR102906752B1 (en) Foam toothpaste composition with excellent calculus formation inhibition ability
KR101660467B1 (en) Oral composition containing fermentative extract of lycii fructus as active ingredient
KR20190094987A (en) Composition for prevention or treatment of oral disease comprising Ginkgo biloba extract
KR102789770B1 (en) Foam toothpaste composition for oral care
KR101916377B1 (en) Composition for teeth whitening and preparation method therefor
KR102380075B1 (en) Composition for preventing or treating oral disease comprising extracts of Stewartia pseudocamellia Maxim.
CN103690452B (en) Composition and method for preventing and treating oral diseases
KR102230888B1 (en) Toothpaste composition
KR20170142740A (en) Composition for treating or preventing oral diseases comprising natural complex
KR102704053B1 (en) Manufacturing method of toothpaste composition including ingredient of improving oral dryness
KR20160147523A (en) Composition for promoting oral hygiene
KR102756051B1 (en) Composition for prevention or treatment of oral disease comprising Lithospermum erythrorhizon extract
RU2824359C1 (en) Mouthwash composition for children

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000